Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
223.4 USD | +3.29% |
|
+10.59% | -5.58% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.58% | 11.14B | |
+24.06% | 46.56B | |
+45.38% | 41.67B | |
-0.47% | 41.16B | |
+33.41% | 32.4B | |
+20.63% | 28.18B | |
-6.35% | 28.1B | |
+49.42% | 14.52B | |
+47.50% | 13.74B | |
+1.98% | 12.17B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Stephens Adjusts Price Target on Charles River Laboratories International to $250 From $280